Doximity Stock Price, News & Analysis (NASDAQ:DOCS)

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings or view top-rated stocks.

9 analysts have issued 12 month target prices for Doximity's stock. Their DOCS share price targets range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $28.40 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price.
View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts.

Doximity's stock was trading at $33.56 at the beginning of the year. Since then, DOCS stock has decreased by 27.4% and is now trading at $24.35.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our DOCS earnings forecast.

Doximity, Inc. (NASDAQ:DOCS) released its earnings results on Thursday, November, 9th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.13 by $0.05. The business earned $113.61 million during the quarter, compared to analyst estimates of $109.19 million. Doximity had a net margin of 27.47% and a trailing twelve-month return on equity of 14.26%.

ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Jacob Forward ETF (JFWD), Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Syntax Stratified MidCap ETF (SMDY), Natixis U.S. Equity Opportunities ETF (EQOP) and BlackRock Future Innovators ETF (BFTR).

(DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

Doximity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (3.81%), Baillie Gifford & Co. (3.42%), Clearbridge Investments LLC (3.10%), Loomis Sayles & Co. L P (1.38%), FMR LLC (1.07%) and Bank of New York Mellon Corp (0.63%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends.

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.